| UniProt ID | PCBP1_HUMAN | |
|---|---|---|
| UniProt AC | Q15365 | |
| Protein Name | Poly(rC)-binding protein 1 | |
| Gene Name | PCBP1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 356 | |
| Subcellular Localization | Nucleus. Cytoplasm. Loosely bound in the nucleus. May shuttle between the nucleus and the cytoplasm. | |
| Protein Description | Single-stranded nucleic acid binding protein that binds preferentially to oligo dC. In case of infection by poliovirus, plays a role in initiation of viral RNA replication in concert with the viral protein 3CD. [PubMed: 12414943] | |
| Protein Sequence | MDAGVTESGLNVTLTIRLLMHGKEVGSIIGKKGESVKRIREESGARINISEGNCPERIITLTGPTNAIFKAFAMIIDKLEEDINSSMTNSTAASRPPVTLRLVVPATQCGSLIGKGGCKIKEIRESTGAQVQVAGDMLPNSTERAITIAGVPQSVTECVKQICLVMLETLSQSPQGRVMTIPYQPMPASSPVICAGGQDRCSDAAGYPHATHDLEGPPLDAYSIQGQHTISPLDLAKLNQVARQQSHFAMMHGGTGFAGIDSSSPEVKGYWASLDASTQTTHELTIPNNLIGCIIGRQGANINEIRQMSGAQIKIANPVEGSSGRQVTITGSAASISLAQYLINARLSSEKGMGCS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MDAGVTES -------CCCCCCCC | 7.81 | 22814378 | |
| 23 | Sumoylation | IRLLMHGKEVGSIIG EEHHHCCHHHHHHCC | 34.25 | 19608861 | |
| 23 | Sumoylation | IRLLMHGKEVGSIIG EEHHHCCHHHHHHCC | 34.25 | - | |
| 23 | Acetylation | IRLLMHGKEVGSIIG EEHHHCCHHHHHHCC | 34.25 | 22638039 | |
| 23 | Ubiquitination | IRLLMHGKEVGSIIG EEHHHCCHHHHHHCC | 34.25 | 21890473 | |
| 27 | Phosphorylation | MHGKEVGSIIGKKGE HCCHHHHHHCCCCCC | 19.06 | 30108239 | |
| 31 | Sumoylation | EVGSIIGKKGESVKR HHHHHCCCCCCHHHH | 47.39 | - | |
| 31 | Sumoylation | EVGSIIGKKGESVKR HHHHHCCCCCCHHHH | 47.39 | - | |
| 31 | Acetylation | EVGSIIGKKGESVKR HHHHHCCCCCCHHHH | 47.39 | 26051181 | |
| 31 | Ubiquitination | EVGSIIGKKGESVKR HHHHHCCCCCCHHHH | 47.39 | 21906983 | |
| 32 | Ubiquitination | VGSIIGKKGESVKRI HHHHCCCCCCHHHHH | 63.80 | 21890473 | |
| 35 | Phosphorylation | IIGKKGESVKRIREE HCCCCCCHHHHHHHH | 41.42 | - | |
| 37 | Acetylation | GKKGESVKRIREESG CCCCCHHHHHHHHHC | 51.92 | 24848933 | |
| 43 | Phosphorylation | VKRIREESGARINIS HHHHHHHHCCCEEEC | 32.76 | - | |
| 50 | Phosphorylation | SGARINISEGNCPER HCCCEEECCCCCCCE | 34.66 | 21815630 | |
| 54 | Glutathionylation | INISEGNCPERIITL EEECCCCCCCEEEEE | 5.64 | 22555962 | |
| 54 | S-palmitoylation | INISEGNCPERIITL EEECCCCCCCEEEEE | 5.64 | 29575903 | |
| 60 | Phosphorylation | NCPERIITLTGPTNA CCCCEEEEEECHHHH | 18.85 | 22817900 | |
| 74 | Sulfoxidation | AIFKAFAMIIDKLEE HHHHHHHHHHHHHHH | 1.92 | 30846556 | |
| 85 | Phosphorylation | KLEEDINSSMTNSTA HHHHHHHHHCCCCCC | 23.09 | 25850435 | |
| 86 | Phosphorylation | LEEDINSSMTNSTAA HHHHHHHHCCCCCCC | 25.74 | 25850435 | |
| 87 | Sulfoxidation | EEDINSSMTNSTAAS HHHHHHHCCCCCCCC | 4.06 | 30846556 | |
| 88 | Phosphorylation | EDINSSMTNSTAASR HHHHHHCCCCCCCCC | 28.15 | 25850435 | |
| 90 | Phosphorylation | INSSMTNSTAASRPP HHHHCCCCCCCCCCC | 15.40 | 25850435 | |
| 91 | Phosphorylation | NSSMTNSTAASRPPV HHHCCCCCCCCCCCE | 28.45 | 25850435 | |
| 99 | Phosphorylation | AASRPPVTLRLVVPA CCCCCCEEEEEEEEH | 16.37 | - | |
| 107 | Phosphorylation | LRLVVPATQCGSLIG EEEEEEHHHHHHHCC | 20.51 | 28450419 | |
| 109 | Glutathionylation | LVVPATQCGSLIGKG EEEEHHHHHHHCCCC | 3.29 | 22555962 | |
| 109 | S-nitrosylation | LVVPATQCGSLIGKG EEEEHHHHHHHCCCC | 3.29 | 2212679 | |
| 109 | S-palmitoylation | LVVPATQCGSLIGKG EEEEHHHHHHHCCCC | 3.29 | 29575903 | |
| 111 | Phosphorylation | VPATQCGSLIGKGGC EEHHHHHHHCCCCCC | 25.17 | 28450419 | |
| 115 | Malonylation | QCGSLIGKGGCKIKE HHHHHCCCCCCEEEH | 45.17 | 26320211 | |
| 115 | Sumoylation | QCGSLIGKGGCKIKE HHHHHCCCCCCEEEH | 45.17 | - | |
| 115 | Ubiquitination | QCGSLIGKGGCKIKE HHHHHCCCCCCEEEH | 45.17 | 21906983 | |
| 115 | Acetylation | QCGSLIGKGGCKIKE HHHHHCCCCCCEEEH | 45.17 | 25953088 | |
| 115 | Sumoylation | QCGSLIGKGGCKIKE HHHHHCCCCCCEEEH | 45.17 | 28112733 | |
| 119 | Ubiquitination | LIGKGGCKIKEIRES HCCCCCCEEEHHHHH | 61.15 | - | |
| 126 | Phosphorylation | KIKEIRESTGAQVQV EEEHHHHHHCCEEEE | 23.46 | 25627689 | |
| 127 | Phosphorylation | IKEIRESTGAQVQVA EEHHHHHHCCEEEEE | 31.61 | 25159151 | |
| 137 | Sulfoxidation | QVQVAGDMLPNSTER EEEEECCCCCCCCCC | 7.02 | 30846556 | |
| 147 | Phosphorylation | NSTERAITIAGVPQS CCCCCCEECCCCCHH | 12.09 | 29496963 | |
| 147 | O-linked_Glycosylation | NSTERAITIAGVPQS CCCCCCEECCCCCHH | 12.09 | OGP | |
| 154 | Phosphorylation | TIAGVPQSVTECVKQ ECCCCCHHHHHHHHH | 25.57 | 21712546 | |
| 156 | O-linked_Glycosylation | AGVPQSVTECVKQIC CCCCHHHHHHHHHHH | 28.99 | OGP | |
| 158 | Glutathionylation | VPQSVTECVKQICLV CCHHHHHHHHHHHHH | 3.19 | 22555962 | |
| 158 | S-palmitoylation | VPQSVTECVKQICLV CCHHHHHHHHHHHHH | 3.19 | 26865113 | |
| 169 | Phosphorylation | ICLVMLETLSQSPQG HHHHHHHHHCCCCCC | 27.96 | 23927012 | |
| 171 | Phosphorylation | LVMLETLSQSPQGRV HHHHHHHCCCCCCCE | 35.71 | 22167270 | |
| 173 | Phosphorylation | MLETLSQSPQGRVMT HHHHHCCCCCCCEEE | 18.80 | 29255136 | |
| 180 | Phosphorylation | SPQGRVMTIPYQPMP CCCCCEEEECCCCCC | 18.88 | 21945579 | |
| 183 | Nitration | GRVMTIPYQPMPASS CCEEEECCCCCCCCC | 22.77 | - | |
| 183 | Phosphorylation | GRVMTIPYQPMPASS CCEEEECCCCCCCCC | 22.77 | 23401153 | |
| 189 | Phosphorylation | PYQPMPASSPVICAG CCCCCCCCCCEEEEC | 29.33 | 29255136 | |
| 190 | Phosphorylation | YQPMPASSPVICAGG CCCCCCCCCEEEECC | 25.87 | 29255136 | |
| 194 | Glutathionylation | PASSPVICAGGQDRC CCCCCEEEECCCCHH | 2.68 | 22555962 | |
| 202 | Phosphorylation | AGGQDRCSDAAGYPH ECCCCHHHCCCCCCC | 31.04 | 28387310 | |
| 207 | Phosphorylation | RCSDAAGYPHATHDL HHHCCCCCCCCCCCC | 6.26 | 28152594 | |
| 211 | Phosphorylation | AAGYPHATHDLEGPP CCCCCCCCCCCCCCC | 16.94 | 28152594 | |
| 222 | Phosphorylation | EGPPLDAYSIQGQHT CCCCCCCEEECCCCC | 13.13 | 21082442 | |
| 223 | Phosphorylation | GPPLDAYSIQGQHTI CCCCCCEEECCCCCC | 15.34 | 23401153 | |
| 229 | Phosphorylation | YSIQGQHTISPLDLA EEECCCCCCCHHHHH | 18.43 | 25159151 | |
| 231 | Phosphorylation | IQGQHTISPLDLAKL ECCCCCCCHHHHHHH | 22.14 | 25159151 | |
| 237 | Ubiquitination | ISPLDLAKLNQVARQ CCHHHHHHHHHHHHH | 56.09 | - | |
| 246 | Phosphorylation | NQVARQQSHFAMMHG HHHHHHHHCHHHCCC | 16.54 | 28176443 | |
| 250 | Sulfoxidation | RQQSHFAMMHGGTGF HHHHCHHHCCCCCCC | 1.67 | 30846556 | |
| 251 | Sulfoxidation | QQSHFAMMHGGTGFA HHHCHHHCCCCCCCC | 2.08 | 30846556 | |
| 255 | Phosphorylation | FAMMHGGTGFAGIDS HHHCCCCCCCCCCCC | 33.45 | 28176443 | |
| 262 | Phosphorylation | TGFAGIDSSSPEVKG CCCCCCCCCCCCCCE | 30.69 | 25159151 | |
| 263 | Phosphorylation | GFAGIDSSSPEVKGY CCCCCCCCCCCCCEE | 46.28 | 28176443 | |
| 264 | Phosphorylation | FAGIDSSSPEVKGYW CCCCCCCCCCCCEEE | 29.09 | 25159151 | |
| 268 | Sumoylation | DSSSPEVKGYWASLD CCCCCCCCEEEEEEC | 44.62 | - | |
| 270 | Phosphorylation | SSPEVKGYWASLDAS CCCCCCEEEEEECCC | 7.65 | 26074081 | |
| 273 | Phosphorylation | EVKGYWASLDASTQT CCCEEEEEECCCCCC | 16.79 | 28112733 | |
| 277 | Phosphorylation | YWASLDASTQTTHEL EEEEECCCCCCEEEE | 22.25 | 24275569 | |
| 280 | Phosphorylation | SLDASTQTTHELTIP EECCCCCCEEEEECC | 30.15 | 27251275 | |
| 281 | Phosphorylation | LDASTQTTHELTIPN ECCCCCCEEEEECCC | 11.97 | 28348404 | |
| 306 | Methylation | GANINEIRQMSGAQI CCCHHHHHHHCCCEE | 21.70 | - | |
| 308 | Sulfoxidation | NINEIRQMSGAQIKI CHHHHHHHCCCEEEE | 2.61 | 28183972 | |
| 309 | Phosphorylation | INEIRQMSGAQIKIA HHHHHHHCCCEEEEC | 23.73 | 28857561 | |
| 314 | Sumoylation | QMSGAQIKIANPVEG HHCCCEEEECCCCCC | 24.56 | - | |
| 314 | Sumoylation | QMSGAQIKIANPVEG HHCCCEEEECCCCCC | 24.56 | - | |
| 314 | Ubiquitination | QMSGAQIKIANPVEG HHCCCEEEECCCCCC | 24.56 | 21890473 | |
| 322 | Phosphorylation | IANPVEGSSGRQVTI ECCCCCCCCCCEEEE | 19.00 | 30108239 | |
| 323 | Phosphorylation | ANPVEGSSGRQVTIT CCCCCCCCCCEEEEE | 49.18 | 25159151 | |
| 328 | Phosphorylation | GSSGRQVTITGSAAS CCCCCEEEEECCHHH | 12.41 | 28857561 | |
| 328 | O-linked_Glycosylation | GSSGRQVTITGSAAS CCCCCEEEEECCHHH | 12.41 | 23301498 | |
| 330 | O-linked_Glycosylation | SGRQVTITGSAASIS CCCEEEEECCHHHHH | 18.73 | 23301498 | |
| 330 | Phosphorylation | SGRQVTITGSAASIS CCCEEEEECCHHHHH | 18.73 | 20068231 | |
| 332 | Phosphorylation | RQVTITGSAASISLA CEEEEECCHHHHHHH | 16.41 | 26657352 | |
| 335 | Phosphorylation | TITGSAASISLAQYL EEECCHHHHHHHHHH | 16.66 | 24719451 | |
| 337 | Phosphorylation | TGSAASISLAQYLIN ECCHHHHHHHHHHHH | 18.37 | 20068231 | |
| 341 | Phosphorylation | ASISLAQYLINARLS HHHHHHHHHHHHHHH | 12.16 | 20068231 | |
| 351 | Acetylation | NARLSSEKGMGCS-- HHHHHCCCCCCCC-- | 57.03 | 23749302 | |
| 351 | Ubiquitination | NARLSSEKGMGCS-- HHHHHCCCCCCCC-- | 57.03 | 21890473 | |
| 356 | Phosphorylation | SEKGMGCS------- CCCCCCCC------- | 37.21 | 24719451 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PCBP1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PCBP1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 AND SER-190, ANDMASS SPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189 AND SER-190, ANDMASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 AND SER-190, ANDMASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 AND SER-190, ANDMASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190, AND MASSSPECTROMETRY. | |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 AND SER-264, ANDMASS SPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173; SER-246; SER-262;SER-263 AND SER-264, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, AND MASSSPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, AND MASSSPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190, AND MASSSPECTROMETRY. | |